DK1629002T3 - Fremgangsmåde til syntetisering af konformationalt hæmmede peptider, peptidometika og anvendelse deraf som syntetiske vacciner - Google Patents

Fremgangsmåde til syntetisering af konformationalt hæmmede peptider, peptidometika og anvendelse deraf som syntetiske vacciner

Info

Publication number
DK1629002T3
DK1629002T3 DK04739532T DK04739532T DK1629002T3 DK 1629002 T3 DK1629002 T3 DK 1629002T3 DK 04739532 T DK04739532 T DK 04739532T DK 04739532 T DK04739532 T DK 04739532T DK 1629002 T3 DK1629002 T3 DK 1629002T3
Authority
DK
Denmark
Prior art keywords
peptides
peptidometics
inhibited
relates
link
Prior art date
Application number
DK04739532T
Other languages
Danish (da)
English (en)
Inventor
Gerd Pluschke
Ursula Kienzl
John Robinson
Rinaldo Zurbriggen
Original Assignee
Mymetics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mymetics Corp filed Critical Mymetics Corp
Application granted granted Critical
Publication of DK1629002T3 publication Critical patent/DK1629002T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK04739532T 2003-06-02 2004-06-02 Fremgangsmåde til syntetisering af konformationalt hæmmede peptider, peptidometika og anvendelse deraf som syntetiske vacciner DK1629002T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03012520A EP1484336A1 (fr) 2003-06-02 2003-06-02 Méthode de synthèse de peptides à constrained de conformation, peptidomimetiques et leur utilisation comme vaccins
PCT/EP2004/005952 WO2004106366A1 (fr) 2003-06-02 2004-06-02 Procedes de synthese de peptides a contrainte conformationnelle, peptidomimetiques associes et leur utilisation en tant que vaccins de synthese

Publications (1)

Publication Number Publication Date
DK1629002T3 true DK1629002T3 (da) 2009-04-14

Family

ID=33155135

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04739532T DK1629002T3 (da) 2003-06-02 2004-06-02 Fremgangsmåde til syntetisering af konformationalt hæmmede peptider, peptidometika og anvendelse deraf som syntetiske vacciner

Country Status (9)

Country Link
US (2) US7569541B2 (fr)
EP (2) EP1484336A1 (fr)
AT (1) ATE420100T1 (fr)
AU (1) AU2004242787B9 (fr)
CA (1) CA2527795C (fr)
DE (1) DE602004018916D1 (fr)
DK (1) DK1629002T3 (fr)
ES (1) ES2320660T3 (fr)
WO (1) WO2004106366A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207646B1 (en) * 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
EP2014279A1 (fr) 2007-06-22 2009-01-14 Pevion Biotech AG Virosomes contenant de l'hémagglutinine dérivée du virus de la grippe produit par les lignées cellulaires; les compositions, les méthodes de production, l'emploi des virosomes
WO2011056561A1 (fr) * 2009-10-27 2011-05-12 Beth Israel Deaconess Medical Center Procédés et compositions pour la génération et l'utilisation d'anticorps spécifiques à une conformation
EP2542571B1 (fr) 2010-03-03 2016-05-25 The University of British Columbia Epitope d'amyloïde bêta spécifique de l'oligomère et anticorps
US10487114B2 (en) * 2011-04-27 2019-11-26 Beth Israel Deaconess Medical Center, Inc. Methods for administering peptides for the generation of effective c/s conformation-specific antibodies to a human subject in need thereof
ES2835716T3 (es) 2013-03-15 2021-06-23 Beth Israel Deaconess Medical Ct Inc Procedimientos y composiciones para la generación y el uso de anticuerpos específicos de conformación
US10774120B2 (en) 2015-11-09 2020-09-15 The University Of British Columbia Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
DE102016100898B4 (de) * 2016-01-20 2021-08-12 Infineon Technologies Ag Chipkarte und Verfahren zum Ausbilden einer Chipkarte
US11524979B2 (en) * 2017-06-15 2022-12-13 University Of Washington Macrocyclic polypeptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989010935A1 (fr) * 1988-05-09 1989-11-16 Abbott Laboratories DERIVES DE PEPTIDES DE l'ATRIUM

Also Published As

Publication number Publication date
US20110008414A9 (en) 2011-01-13
AU2004242787B9 (en) 2010-10-14
AU2004242787B8 (en) 2010-07-15
ATE420100T1 (de) 2009-01-15
DE602004018916D1 (de) 2009-02-26
WO2004106366A8 (fr) 2005-02-03
AU2004242787B2 (en) 2010-05-27
US20060258564A1 (en) 2006-11-16
EP1629002A1 (fr) 2006-03-01
EP1484336A1 (fr) 2004-12-08
EP1629002B1 (fr) 2009-01-07
US7569541B2 (en) 2009-08-04
CA2527795C (fr) 2014-04-22
US20090324707A1 (en) 2009-12-31
AU2004242787A1 (en) 2004-12-09
CA2527795A1 (fr) 2004-12-09
WO2004106366A1 (fr) 2004-12-09
ES2320660T3 (es) 2009-05-27

Similar Documents

Publication Publication Date Title
WO2021243122A3 (fr) Protéine de spicule (s) de coronavirus génétiquement modifiée et ses procédés d'utilisation
NZ798475A (en) Prefusion-stabilized hmpv f proteins
NO20082716L (no) Sammensetninger og fremgangsmater for fremstilling av en sammensetning
DE602004001727D1 (de) Verfahren zur herstellung cyclischer peptide
PE20140986A1 (es) Proteinas de fusion y vacunas de combinacion que comprenden proteina e y pilina a de haemophilus influenzae
BRPI0715396B8 (pt) método de produção de uma composição para vacina
NO20092774L (no) HLA-A*1101-begrenset WT1-peptid og farmasoytisk preparat som omfatter dette
DK1680509T3 (da) Fremgangsmåde til fremstilling af carbonhydrider og oxygenholdige forbindelser fra biomasse der inkluderer fermentation med tilsætning af aminosyre (leu, ile, val)
DE602005008996D1 (de) Radiofluorierte peptide
CY1107146T1 (el) Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad)
IL226857A0 (en) Recombinant proteins that have undergone n-site glycosylation in prokaryotic cells
WO2006031811A3 (fr) Interferon alpha glycopegyle
ES2572260T3 (es) Péptidos útiles en el tratamiento y/o cuidado de la piel y/o membranas mucosas y su uso en composiciones cosméticas o farmacéuticas
DE602006011099D1 (de) Verfahren zur herstellung von peptidderivaten
BR0211296A (pt) Peptìdeo imunogênico derivado da proteìna g do vrs do sub-grupo a ou b, sequência de ácido nucleico, composição farmacêutica, anticorpos policlonais ou monoclonais, kit de diagnóstico, utilização de um peptìdeo imunogênico, e, conjugado
DK1954308T3 (da) Stabiliseringsmidler til frysetørrede vacciner
BR0211761A (pt) depsipeptìdeos e processos para preparar os mesmos
MX337756B (es) Peptido de epitope hig2 y urlc10 y vacunas que contienen el mismo.
WO2004106366A8 (fr) Procedes de synthese de peptides a contrainte conformationnelle, peptidomimetiques associes et leur utilisation en tant que vaccins de synthese
ATE427117T1 (de) Verwendung nativer peptide und deren optimierter derivate zur impfung
UA97092C2 (ru) T-клеточные эпитопы с раково-эмбрионального антиген-незрелого рецепторного белка ламинина и их медицинское применение
MX2011004176A (es) Peptido-epitope rab6kifl/kif20a y vacunas que contienen el mismo.
WO2006014429A3 (fr) Conjugues peptidiques de cidofovir utilises comme promedicaments
WO2006103101A3 (fr) Moyens pour l'inhibition d'anticorps anti-recepteurs $g(b)1 adrenergiques
NO20062579L (no) Preparater som omfatter melittin-avledede peptider og fremgangsmate for styrking av immunresponser mot malantigener